FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Charles Shield

Research Profile

Procedures

Living Beings

Physiology

Anatomy

ABO Blood-Group System

Activities & Behaviors

Tissue and Organ Procurement

Chemicals & Drugs

Geographic Areas

Midwestern United States

Disorders

Blood Group Incompatibility

Concepts & Ideas

Organizations

Tissue Banks

Co-author Network

Publications

TOP 3
Christopher F Bryan; Paul W Nelson; Charles F Shield; Bradley A Warady; Franz T Winklhofer; Daniel Murillo; M R Wakefield
Long-term survival of kidneys transplanted from live A2 donors to O and B recipients.
Christopher F Bryan; Mark Wakefield; Jeffrey C Reese; Charles F Shield; Bradley A Warady; Franz T Winklhofer; Daniel Murillo
Renal graft survival is not influenced by a positive flow B-cell crossmatch.
Christopher F Bryan; Scott B McDonald; Alan M Luger; Charles F Shield; Franz T Winklhofer; A Michael Borkon; Bradley A Warady; Mark I Aeder; Daniel Murillo
Successful renal transplantation despite low levels of donor-specific HLA class I antibody without IVIg or plasmapheresis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Charles Shield (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Christopher F Bryan; Paul W Nelson; Charles F Shield; Bradley A Warady; Franz T Winklhofer; Daniel Murillo; M R Wakefield
Long-term survival of kidneys transplanted from live A2 donors to O and B recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(5):1181-4.
2007: Christopher F Bryan; Mark Wakefield; Jeffrey C Reese; Charles F Shield; Bradley A Warady; Franz T Winklhofer; Daniel Murillo
Renal graft survival is not influenced by a positive flow B-cell crossmatch.
Clinical transplantation 2007;21(1):72-9.
2006: Christopher F Bryan; Scott B McDonald; Alan M Luger; Charles F Shield; Franz T Winklhofer; A Michael Borkon; Bradley A Warady; Mark I Aeder; Daniel Murillo
Successful renal transplantation despite low levels of donor-specific HLA class I antibody without IVIg or plasmapheresis.
Clinical transplantation 2006;20(5):563-70.
2005: Christopher F Bryan; Franz T Winklhofer; Daniel Murillo; Gilbert Ross; Paul W Nelson; Charles F Shield; Bradley A Warady
Improving access to kidney transplantation without decreasing graft survival: long-term outcomes of blood group A2/A2B deceased donor kidneys in B recipients.
Transplantation 2005;80(1):75-80.
2004: Christopher F Bryan; Paul W Nelson; Charles F Shield; Gilbert Ross; Bradley A Warady; Daniel Murillo; Franz T Winklhofer
Transplantation of A2 and A2B kidneys from deceased donors into B waiting list candidates increases their transplantation rate.
Clinical transplants 2004;():127-33.
2004: Christopher F Bryan; Wida S Cherikh; Yulin Cheng; Mark I Aeder; Nicolas A Muruve; Paul W Nelson; Charles F Shield; Bradley A Warady; Franz T Winklhofer
ABO blood group influences a candidate's likelihood of receiving an HLA zero antigen mismatch kidney.
Clinical transplantation 2004;18 Suppl 12():55-60.
2004: Christopher F Bryan; Gary E Tegtmeier; Nour Rafik; Lori E Markham; Daniel Murillo; Paul W Nelson; Charles F Shield; Bradley A Warady; Mark I Aeder
The risk for Chagas' disease in the Midwestern United States organ donor population is low.
Clinical transplantation 2004;18 Suppl 12():12-5.
2003: Christopher F Bryan; Kevin M Harrell; Stanley I Mitchell; Bradley A Warady; Mark I Aeder; Alan M Luger; Daniel Murillo; Nicolas A Muruve; Paul W Nelson; Charles F Shield
HLA points assigned in cadaveric kidney allocation should be revisited: an analysis of HLA class II molecularly typed patients and donors.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2003;3(4):459-64.
2003: Karen A Baier; L E Markham; S P Flaigle; Paul W Nelson; Charles F Shield; Nicolas A Muruve; Mark I Aeder; Daniel Murillo; Christopher F Bryan
Point-of-care testing in an organ procurement organization donor management setting.
Clinical transplantation 2003;17 Suppl 9():48-51.
2002: Christopher F Bryan; Scott B McDonald; Karen A Baier; Alan M Luger; Mark I Aeder; Daniel Murillo; Nicolas A Muruve; Paul W Nelson; Charles F Shield; Bradley A Warady
Flow cytometry beads rather than the antihuman globulin method should be used to detect HLA Class I IgG antibody (PRA) in cadaveric renal regraft candidates.
Clinical transplantation 2002;16 Suppl 7():15-23.
2002: Paul W Nelson; Charles F Shield; Nicolas A Muruve; Daniel Murillo; Bradley A Warady; Mark I Aeder; Christopher F Bryan
Increased access to transplantation for blood group B cadaveric waiting list candidates by using A2 kidneys: time for a new national system?
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2002;2(1):94-9.
2001: Nicolas A Muruve; Thomas S Helling; Alan M Luger; J Martinez; Paul W Nelson; GE Pierce; Gilbert Ross; Charles F Shield; Bradley A Warady; Mark I Aeder; Christopher F Bryan
Effect of donor brain-death duration on graft outcome.
Transplantation proceedings 2001;33(6):2980-1.
2001: Christopher F Bryan; Alan M Luger; J Martinez; Nicolas A Muruve; Paul W Nelson; GE Pierce; Gilbert Ross; Charles F Shield; Bradley A Warady; Mark I Aeder; Thomas S Helling
Cold ischemia time: an independent predictor of increased HLA class I antibody production after rejection of a primary cadaveric renal allograft.
Transplantation 2001;71(7):875-9.
2001: Christopher F Bryan; J Martinez; Nicolas A Muruve; Paul W Nelson; GE Pierce; Gilbert Ross; Charles F Shield; Bradley A Warady; Mark I Aeder; Kevin M Harrell; Thomas S Helling; Alan M Luger
IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotype.
Clinical transplantation 2001;15 Suppl 6():28-35.
2001: Paul W Nelson; Mark I Aeder; W Andrews; J Forster; Nicolas A Muruve; Charles F Shield; J Finn; Christopher F Bryan
The influence of age, gender and ethnicity on cadaveric organ recovery rate.
Clinical transplantation 2001;15 Suppl 6():6-10.
2000: Christopher F Bryan; Charles F Shield; GE Pierce; Bradley A Warady; Mark I Aeder; J Martinez; Alan M Luger; Paul W Nelson; Gilbert Ross; Nicolas A Muruve; Stanley I Mitchell
Successful cadaveric renal transplantation of patients highly sensitized to HLA Class I antigens.
Clinical transplantation 2000;14(1):79-84.
1999: Christopher F Bryan; Charles F Shield; Bradley A Warady; Mark I Aeder; Thomas S Helling; Alan M Luger; J Martinez; Paul W Nelson; GE Pierce; Gilbert Ross; Nicolas A Muruve; E R Thien
Influence of an historically positive crossmatch on cadaveric renal transplantation.
Transplantation proceedings 1999;31(1-2):225-7.
1998: Christopher F Bryan; Karen A Baier; Paul W Nelson; Alan M Luger; J Martinez; GE Pierce; Gilbert Ross; Charles F Shield; Bradley A Warady; Mark I Aeder; Thomas S Helling; Nicolas A Muruve
Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatching.
Transplantation 1998;66(12):1827-32.
1998: Christopher F Bryan; Charles F Shield; Paul W Nelson; GE Pierce; Gilbert Ross; Alan M Luger; Bradley A Warady; Thomas S Helling; Mark I Aeder; J Martinez; T M Hughes; M L Beck; Kevin M Harrell
Transplantation rate of the blood group B waiting list is increased by using A2 and A2B kidneys.
Transplantation 1998;66(12):1714-7.
1998: Christopher F Bryan; Stanley I Mitchell; H M Lin; Paul W Nelson; Charles F Shield; Alan M Luger; GE Pierce; Gilbert Ross; Bradley A Warady; Mark I Aeder; Thomas S Helling; M D Landreneau; Kevin M Harrell
Influence of the Rh (D) blood group system on graft survival in renal transplantation.
Transplantation 1998;65(4):588-92.
1998: A V Osorio; E Kenneth Sullivan; Steven R Alexander; Christopher F Bryan; Charles F Shield; Bradley A Warady
ABO-mismatched renal transplantation in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) and the Midwest Organ Bank (MOB).
Pediatric transplantation 1998;2(1):26-9.
1998: Paul W Nelson; M D Landreneau; Alan M Luger; GE Pierce; Gilbert Ross; Charles F Shield; Bradley A Warady; Mark I Aeder; Thomas S Helling; T M Hughes; M L Beck; Kevin M Harrell; Christopher F Bryan
Ten-year experience in transplantation of A2 kidneys into B and O recipients.
Transplantation 1998;65(2):256-60.
1996: Christopher F Bryan; Kevin M Harrell; Paul W Nelson; GE Pierce; Gilbert Ross; Charles F Shield; Bradley A Warady; Mark I Aeder; Thomas S Helling; M D Landreneau; Alan M Luger
HLA-DR and DQ typing by polymerase chain reaction using sequence-specific primer mixes reduces the incidence of phenotypic homozygosity (blanks) over serology.
Transplantation 1996;62(12):1819-24.
1996: Christopher F Bryan; Charles F Shield; Bradley A Warady; Mark I Aeder; M D Landreneau; Alan M Luger; Paul W Nelson; GE Pierce; Gilbert Ross
Allocation of kidneys to Afro-American patients is proportional to wait-list composition.
Transplantation proceedings 1996;28(1):219-20.
1996: Alan M Luger; Christopher F Bryan; B J O'Brien; GE Pierce; Charles F Shield; Bradley A Warady; Mark I Aeder; M D Landreneau; Paul W Nelson; Gilbert Ross
Do African-Americans wait longer for a kidney because of HLA class I antibody specificities and panel-reactive antibody sensitization?
Transplantation proceedings 1996;28(1):157-9.
1996: Christopher F Bryan; G E Tegtmeier; A Polito; W Bayer; GE Pierce; Charles F Shield; Bradley A Warady; Mark I Aeder; A M Borkon; T H Estep; J Forster; M D Landreneau; Alan M Luger; Paul W Nelson; Gilbert Ross
Evaluation of the 3.0 Ortho EIA assay in 385 consecutive cadaveric organ donors.
Transplantation proceedings 1996;28(1):155-6.
1995: Christopher F Bryan; K A Baier; G Flora-Ginter; Charles F Shield; Bradley A Warady; Mark I Aeder; A M Borkon; T H Estep; J Forster; M D Landreneau
Detection of HLA IgG antibodies by two enzyme-linked immunoassays, solubilized HLA class I and PRA-STAT. Comparison with the AHG PRA.
Transplantation 1995;60(12):1588-94.
1993: Christopher F Bryan; Mark I Aeder; Alan M Luger; Paul W Nelson; GE Pierce; Gilbert Ross; Charles F Shield; Bradley A Warady
Incidence of a positive final antiglobulin (AHG) T-cell crossmatch in patients waiting for cadaveric renal transplantation is not influenced by race of recipient.
Transplantation proceedings 1993;25(6):3273-4.
1993: Christopher F Bryan; Kevin M Harrell; Mark I Aeder; Alan M Luger; Paul W Nelson; GE Pierce; Gilbert Ross; Charles F Shield; Bradley A Warady
Impact of HLA DR typing by polymerase chain reaction amplification with DR beta 1 sequence-specific primers on cadaveric renal allocation.
Transplantation proceedings 1993;25(6):3060-3.
1993: Mark I Aeder; Charles F Shield; G E Tegtmeier; W Bayer; Alan M Luger; Paul W Nelson; GE Pierce; A Polito; J C Wilber; P Johnson
Incidence and clinical impact of hepatitis C virus-positive donors in cadaveric transplantation.
Transplantation proceedings 1993;25(1 Pt 2):1469-71.
1992: Christopher F Bryan; Paul W Nelson; Mark I Aeder; M L Beck; Thomas S Helling; T M Hughes; Alan M Luger; GE Pierce; Charles F Shield
Current experience with renal transplantation across the ABO blood group barrier.
Transplantation proceedings 1992;24(6):2527-9.
1992: Christopher F Bryan; Mark I Aeder; Thomas S Helling; Alan M Luger; Paul W Nelson; GE Pierce; Charles F Shield; A Thomas
Influence of race, PRA level, and gender on the incidence of a positive donor-specific preliminary T cell crossmatch.
Transplantation proceedings 1992;24(6):2517-8.
1992: Christopher F Bryan; Mark I Aeder; Thomas S Helling; J Hughes; Alan M Luger; Paul W Nelson; GE Pierce; Charles F Shield; Bradley A Warady
Influence of HLA and race on long-term cadaveric renal transplantation.
Transplantation proceedings 1992;24(6):2451-3.
1992: Paul W Nelson; Thomas S Helling; Charles F Shield; M Beck; Christopher F Bryan
Current experience with renal transplantation across the ABO barrier.
American journal of surgery 1992;164(5):541-4; discussion 544-5.
1988: Paul W Nelson; Thomas S Helling; G E Pierce; Gilbert Ross; Charles F Shield; M L Beck; B Blake; D E Cross
Successful transplantation of blood group A2 kidneys into non-A recipients.
Transplantation 1988;45(2):316-9.